Medindia
Advertisement

'Encouraging' Results of Ebola Drug Trial in Guinea

by Himabindu Venkatakrishnan on February 5, 2015 at 9:53 PM
Font : A-A+

'Encouraging' Results of Ebola Drug Trial in Guinea

"Encouraging" results were seen in an Ebola candidate during a trial among a sample of 80 patients in Guinea, where the medics observed faster recovery rates, the French government and medical research agency Inserm said today.

No scientific trial data has been made public, but the preliminary results are the first to show efficacy of an experimental treatment for the Ebola virus which has infected 22,495 people and killed 8,981 in the worst outbreak in history, according to the latest tally by the World Health Organization.

Advertisement

"Encouraging results of the trial" with Japanese-manufactured anti-viral drug favipiravir "will be submitted shortly to a scientific journal for publication", an Inserm statement to AFP said.

The French government said in a separate statement that faster recovery rates were reported among the 80 infected adults and children who received the drug.
Advertisement

The results "show a reduction in the number of deaths among adults and teenagers, with slower virus multiplication. Recovery is accelerated," said the Elysee palace.

The head of France's Ebola Task Force, Jean-Francois Delfraissy, and Inserm head Yves Levy briefed President Francois Hollande and government officials on Wednesday, it added, and described the results as "an important step forward".

Inserm is in charge of the trial at a treatment centre in Gueckedou in the east of Guinea — one of the three countries, with Liberia and Sierra Leone, hardest hit by the outbreak.

The trial, which started on December 17, was conducted in partnership with Guinean researchers and authorities, non-government organisations, the French Red Cross and aid group Doctors Without Borders (MSF).

It is the largest clinical trial yet with a candidate Ebola treatment, the French statement said.

Favipiravir, also known as Avigan, is developed by Toyama Chemical, a subsidiary of Fujifilm Holdings.

Inserm said the scientific results will be made public once they have been officially reviewed and validated by the scientific community, which could happen by month's end.

The drug has already been administered as an emergency treatment to patients evacuated from West Africa to Europe, though this was not part of an official trial.

It has commercial authorisation in Japan as a flu medicine, and large doses can be made quickly available — an advantage over other experimental treatments, like ZMapp, of which stocks are limited.

The Elysee said the results gave rise to "hope", but cautioned they have to be confirmed with a larger group of trial patients.

"These early results open new avenues for access to treatment in the fight against this disease," it said — adding the outcome will be discussed Thursday at a meeting between Guinean President Alpha Conde, Delfraissy and Levy.

There is as yet no licensed vaccine or treatment for Ebola. The WHO gave the green light last August for experimental treatment to be used in the current crisis, and several experimental drugs are being fast-tracked through the normally years-long trial process.
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Gonorrhea
World Alzheimer's Day 2021 - 'Know Dementia, Know Alzheimer's
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Signature Drug Toxicity Congo Fever Ebola Virus Disease 

Recommended Reading
Ebola Virus Disease
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have .....
World Support for Ebola: US$35 Million Funding from King Abdallah of Saudi Arabia
Zaire ebolavirus is commonly known as Ebola. It was previously known as ebola haemorrhagic fever ......
Only a Third of Ebola Aid Pledges Delivered
Only about a third of the $2.89 billion in aid money pledged to fight the Ebola virus in west ......
Quiz on Ebola
Why is the deadly Ebola virus outbreak making the health experts hit the panic button? Find out ......
Clinical Trials
Clinical trials are experiments that yield useful information to clinicians if a particular treatmen...
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Clinical Trials - The Past and The Future
Many of the drugs that are used today have been discovered by chance or often by mere ......
Congo Fever
Crimean-Congo Hemorrhagic fever (CCHF) is a viral disease that affects people who are bitten by infe...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use